Right ventricular outflow tract obstruction risk factors: Difference between revisions
Marjan Khan (talk | contribs) |
Marjan Khan (talk | contribs) |
||
| Line 30: | Line 30: | ||
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4]. | Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4]. | ||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
*Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral. | *Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral. <ref name="pmid7743689">{{cite journal |vauthors=Waller BF, Howard J, Fess S |title=Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part II |journal=Clin Cardiol |volume=18 |issue=3 |pages=167–74 |date=March 1995 |pmid=7743689 |doi=10.1002/clc.4960180312 |url=}}</ref> | ||
*Common risk factors in the development of [disease name] include: | *Common risk factors in the development of [disease name] include: | ||
**[Risk factor 1] | **[Risk factor 1] | ||
Revision as of 16:15, 18 February 2020
|
Right ventricular outflow tract obstruction Microchapters |
|
Classification |
|---|
|
Differentiating Right ventricular outflow tract obstruction from other Diseases |
|
Diagnosis |
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Right ventricular outflow tract obstruction risk factors On the Web |
|
FDA on Right ventricular outflow tract obstruction risk factors |
|
CDC on Right ventricular outflow tract obstruction risk factors |
|
Right ventricular outflow tract obstruction risk factors in the news |
|
Blogs on Right ventricular outflow tract obstruction risk factors |
|
Directions to Hospitals Treating Right ventricular outflow tract obstruction risk factors |
|
Risk calculators and risk factors for Right ventricular outflow tract obstruction risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
There are no established risk factors for [disease name]. [1]
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
Common Risk Factors
- Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral. [2]
- Common risk factors in the development of [disease name] include:
- [Risk factor 1]
- [Risk factor 2]
- [Risk factor 3]
Less Common Risk Factors
- Less common risk factors in the development of [disease name] include:
- [Risk factor 1]
- [Risk factor 2]
- [Risk factor 3]
References
- ↑ Rajamannan NM, Nealis TB, Subramaniam M, Pandya S, Stock SR, Ignatiev CI; et al. (2005). "Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation". Circulation. 111 (24): 3296–301. doi:10.1161/CIRCULATIONAHA.104.473165. PMID 15956138.
- ↑ Waller BF, Howard J, Fess S (March 1995). "Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part II". Clin Cardiol. 18 (3): 167–74. doi:10.1002/clc.4960180312. PMID 7743689.
Template:WH Template:WS [[Category: (name of the system)]